TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
45 hedge funds and large institutions have $17M invested in TFF Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
46% more call options, than puts
Call options by funds: $557K | Put options by funds: $381K
0% more funds holding
Funds holding: 45 → 45 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
27% less capital invested
Capital invested by funds: $23.4M → $17M (-$6.41M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sepio Capital
Salt Lake City,
Utah
|
+$1.18M |
| 2 |
VF
Virtu Financial
New York
|
+$112K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$90.6K |
| 4 |
VWM
Venturi Wealth Management
Austin,
Texas
|
+$44.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$40.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$529K |
| 2 |
JP Morgan Chase
New York
|
-$244K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$202K |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
-$135K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$113K |
TFFP Hedge Fund Activity: Q3 2022 in Review
45 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q3 2022, worth a combined $17M — down 27% from $23.4M a quarter earlier.
Fund positioning in TFFP was balanced in Q3 2022: 5 funds opened new positions, 5 closed out, 15 added to existing stakes and 10 trimmed.
The largest buyer was Sepio Capital, adding an estimated $1.18M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $529K sold.
- 45 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $17M of TFF Pharmaceuticals, Inc. Common Stock stock for Q3 2022, down 27% quarter-over-quarter.
- 5 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q3 2022 and 5 closed out, a net change of 0 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q3 2022 was Sepio Capital, an estimated $1.18M added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q3 2022 was GSA Capital Partners, an estimated $529K sold.
Based on aggregated 13F filings for Q3 2022.